ASCO 2021: Presentations about whole genome sequencing

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk Schipper of the Dutch Cancer Institute (NKI) have presented their findings on whole genome sequencing.

In the poster presentation

Whole Genome Sequencing (WGS) is feasible in routine clinical care

Kris Samsom of the Dutch Cancer Institute explains the results of their research in which they conclude that WGS is feasible in routine diagnostics.

In the poster presentation

Whole Genome Sequencing (WGS) improves sarcoma diagnosis and patient care

Luuk Schipper of the Dutch Cancer Institute explains how they came to the conclusion in their research that WGS can help improve the diagnosis and the treatment of patients with sarcomas.

More information

You read an article in the category Scientific publications. You may also be interested in Whole genome sequencing.
All news

Also read

GenomeWeb: ‘Dutch Team Looks to Drug Repurposing to Improve Patient Outcomes, Lower Costs’

GenomeWeb: ‘Dutch Team Looks to Drug Repurposing to Improve Patient Outcomes, Lower Costs’

10-11-2016

The project is an attempt to address the rising healthcare costs associated with new cancer drugs and to identify biomarkers …

Single WGS analysis of metastases is sufficient in most cases

Single WGS analysis of metastases is sufficient in most cases

26-10-2021

DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

21-05-2021

Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl